Terms: = Pancreatic cancer AND PAX8, ENSG00000125618, 7849
36 results:
1. [Cytopathological characterization of ascites for the diagnosis of serous ovarian carcinoma].
Chang YH; Zou BQ; Cai Y; Yang SD; Zhang Y; Liang JB; Li C
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):424-432. PubMed ID: 37188628
[No Abstract] [Full Text] [Related]
2. pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens.
Chi Z; Xu J; Karamchandani DM; Peng L
Diagn Pathol; 2023 Apr; 18(1):54. PubMed ID: 37098593
[TBL] [Abstract] [Full Text] [Related]
3. Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours.
Wang F; Yang Y; Du X; Zhu X; Hu Y; Lu C; Sui L; Zhao H; Song K; Yao Q
BMC Cancer; 2023 Jan; 23(1):44. PubMed ID: 36639622
[TBL] [Abstract] [Full Text] [Related]
4. Cauda Equina Neuroendocrine Tumors: Distinct Epithelial Neuroendocrine Neoplasms of Spinal Origin.
Asa SL; Mete O; Schüller U; Ramani B; Mirchia K; Perry A
Am J Surg Pathol; 2023 Apr; 47(4):469-475. PubMed ID: 36543154
[TBL] [Abstract] [Full Text] [Related]
5. An exceptionally rare case of metastatic high-grade urothelial carcinoma of the renal pelvis to the pancreas diagnosed on endoscopic ultrasound-guided fine-needle aspiration: A diagnostic challenge.
Koyuncuer A; Sayar S; Zemheri IE; Özdil K; Özçelik M
Diagn Cytopathol; 2022 Oct; 50(10):E295-E300. PubMed ID: 35656642
[TBL] [Abstract] [Full Text] [Related]
6. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
Kaur K; Shah A; Gandhi J; Trivedi P
J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
[TBL] [Abstract] [Full Text] [Related]
7. Immunohistochemical expression of carbonic anhydrase 9, glucose transporter 1, and paired box 8 in von Hippel-Lindau disease-related lesions.
Chatzopoulos K; Aubry MC; Gupta S
Hum Pathol; 2022 May; 123():93-101. PubMed ID: 35196526
[TBL] [Abstract] [Full Text] [Related]
8. Adipose-derived mesenchymal stem cells induced pax8 promotes ovarian cancer cell growth by stabilizing TAZ protein.
Chu Y; Zhu C; Wang Q; Liu M; Wan W; Zhou J; Han R; Yang J; Luo W; Liu C; Zhou H; Li M; Yu F; Ye Y
J Cell Mol Med; 2021 May; 25(9):4434-4443. PubMed ID: 33830648
[TBL] [Abstract] [Full Text] [Related]
9. Papillary-cystic neoplasms of the middle ear are distinct from endolymphatic sac tumours.
Taverna C; Pollastri F; Pecci R; Giannoni B; Fattorini C; Santucci M; Mueller SK; Stoehr R; Franchi A; Agaimy A
Histopathology; 2021 Sep; 79(3):306-314. PubMed ID: 32940914
[TBL] [Abstract] [Full Text] [Related]
10. Positivity for SATB2 distinguishes Islet1 positive rectal neuroendocrine tumours from pancreaticoduodenal neuroendocrine tumours.
Mohanty SK; Tiwari A; Bhardwaj N; Chuang F; Kim E; Lugo H; Yuan X; Diffalha SA; Peralta-Venturina M; Balzer B; Dhall D
J Clin Pathol; 2021 Sep; 74(9):582-588. PubMed ID: 32934105
[TBL] [Abstract] [Full Text] [Related]
11. Lymphoid Enhancer Binding Factor 1 (LEF1) and Paired Box Gene 8 (pax8): A Limited Immunohistochemistry Panel to Distinguish Solid Pseudopapillary Neoplasms and pancreatic Neuroendocrine Tumors.
Lu H; Allende D; Liu X; Zhang Y
Appl Immunohistochem Mol Morphol; 2020; 28(10):776-780. PubMed ID: 32723981
[TBL] [Abstract] [Full Text] [Related]
12. Prognosis Based Definition of Resectability in pancreatic cancer: A Road Map to New Guidelines.
Oba A; Croce C; Hosokawa P; Meguid C; Torphy RJ; Al-Musawi MH; Ahrendt S; Gleisner A; Schulick RD; Del Chiaro M
Ann Surg; 2022 Jan; 275(1):175-181. PubMed ID: 32149822
[TBL] [Abstract] [Full Text] [Related]
13. Long non-coding RNA MACC1-AS1 promoted pancreatic carcinoma progression through activation of pax8/NOTCH1 signaling pathway.
Qi C; Xiaofeng C; Dongen L; Liang Y; Liping X; Yue H; Jianshuai J
J Exp Clin Cancer Res; 2019 Aug; 38(1):344. PubMed ID: 31391063
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of pax8 Expression in Breast Carcinoma Using MRQ50 and BC12 Monoclonal Antibodies.
Singh K; Hanley LC; Sung CJ; Quddus MR
Appl Immunohistochem Mol Morphol; 2020 Aug; 28(7):558-561. PubMed ID: 31335489
[TBL] [Abstract] [Full Text] [Related]
15. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate pax8.
Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
[TBL] [Abstract] [Full Text] [Related]
16. Papillary thyroid carcinoma metastatic to the pancreas: Case report.
Cho M; Acosta-Gonzalez G; Brandler TC; Basu A; Wei XJ; Simms A
Diagn Cytopathol; 2019 Mar; 47(3):214-217. PubMed ID: 30479026
[TBL] [Abstract] [Full Text] [Related]
17. Targeting pancreatic expressed PAX genes for the treatment of diabetes mellitus and pancreatic neuroendocrine tumors.
Martin-Montalvo A; Lorenzo PI; López-Noriega L; Gauthier BR
Expert Opin Ther Targets; 2017 Jan; 21(1):77-89. PubMed ID: 27841034
[TBL] [Abstract] [Full Text] [Related]
18. Immunohistochemistry of ductal adenocarcinoma of the prostate and adenocarcinomas of non-prostatic origin: a comparative study.
Seipel AH; Samaratunga H; Delahunt B; Wiklund P; Clements M; Egevad L
APMIS; 2016 Apr; 124(4):263-70. PubMed ID: 26778368
[TBL] [Abstract] [Full Text] [Related]
19. A subset of solitary fibrous tumors express nuclear pax8 and PAX2: a potential diagnostic pitfall.
McDaniel AS; Palanisamy N; Smith SC; Robinson DR; Wu YM; Chinnaiyan AM; McHugh JB; Greenson JK; Kunju LP
Histol Histopathol; 2016 Feb; 31(2):223-30. PubMed ID: 26404914
[TBL] [Abstract] [Full Text] [Related]
20. NKX6-1 Is a Novel Immunohistochemical Marker for pancreatic and Duodenal Neuroendocrine Tumors.
Tseng IC; Yeh MM; Yang CY; Jeng YM
Am J Surg Pathol; 2015 Jun; 39(6):850-7. PubMed ID: 25871618
[TBL] [Abstract] [Full Text] [Related]
[Next]
